| MIR21 |
|
microRNA 21
|
|
|
0.363 |
0.846 |
| MIR155 |
|
microRNA 155
|
|
|
0.384 |
0.885 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| MIR223 |
|
microRNA 223
|
|
|
0.433 |
0.808 |
| KLRC4-KLRK1 |
P26718
|
KLRC4-KLRK1 readthrough
|
|
|
0.469 |
0.769 |
| CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
| MIR214 |
|
microRNA 214
|
|
|
0.480 |
0.808 |
| LINC02605 |
|
long intergenic non-protein coding RNA 2605
|
|
|
0.490 |
0.769 |
| H3P40 |
|
H3 histone pseudogene 40
|
|
|
0.506 |
0.846 |
| SPZ1 |
Q9BXG8
|
spermatogenic leucine zipper 1
|
|
|
0.507 |
0.769 |
| MIR486-1 |
|
microRNA 486-1
|
|
|
0.521 |
0.808 |
| MIR342 |
|
microRNA 342
|
|
|
0.547 |
0.769 |
| TRA |
P0DSE1
|
T cell receptor alpha locus
|
|
|
0.628 |
0.577 |
| TRB |
P0DSE2
|
T cell receptor beta locus
|
|
|
0.636 |
0.538 |
| CNC2 |
|
Carney complex type 2, multiple neoplasia and lentiginosis
|
|
|
0.674 |
0.692 |
| TRBV16 |
A0A087WV62
|
T cell receptor beta variable 16 (gene/pseudogene)
|
|
|
0.695 |
0.500 |
| TRBV7-9 |
P04435
|
T cell receptor beta variable 7-9
|
|
|
0.695 |
0.500 |
| TRBC1 |
P01850
|
T cell receptor beta constant 1
|
|
|
0.695 |
0.500 |
| TRAC |
P01848
|
T cell receptor alpha constant
|
Receptor
|
|
0.691 |
0.615 |
| TRAV29DV5 |
P04437
|
T cell receptor alpha variable 29/delta variable 5 (gene/pseudogene)
|
|
|
0.751 |
0.346 |
| TRAJ60 |
|
T cell receptor alpha joining 60 (pseudogene)
|
|
|
0.751 |
0.346 |
| TET2 |
Q6N021
|
tet methylcytosine dioxygenase 2
|
|
4.3E-54 |
0.458 |
0.808 |
| ATM |
Q13315
|
ATM serine/threonine kinase
|
Kinase
|
5.6E-47 |
0.374 |
0.885 |
| DNMT3A |
Q9Y6K1
|
DNA methyltransferase 3 alpha
|
|
7.4E-39 |
0.445 |
0.846 |
| AHI1 |
Q8N157
|
Abelson helper integration site 1
|
|
1.1E-25 |
0.513 |
0.846 |